Yanrong Zhu Selected Research

Doxorubicin (Adriamycin)

12/2020

Tamoxifen attenuates reactive astrocyte-induced brain metastasis and drug resistance through the IL-6/STAT3 signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanrong Zhu Research Topics

Disease

12	Reperfusion Injury 12/2021 - 01/2013
9	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021 - 01/2013
9	Infarction (Infarctions) 12/2020 - 01/2013
7	Colitis 01/2024 - 10/2020
7	Ischemia 01/2018 - 01/2013
6	Neoplasms (Cancer) 01/2022 - 03/2013
6	Brain Ischemia (Cerebral Ischemia) 12/2019 - 01/2014
4	Experimental Arthritis 04/2023 - 01/2022
4	Myocardial Infarction 01/2023 - 06/2013
3	Wounds and Injuries (Trauma) 01/2019 - 01/2014
3	Hyperglycemia 01/2017 - 01/2015
3	Diabetic Cardiomyopathies 01/2017 - 01/2015
2	Ulcerative Colitis 01/2024 - 06/2023
2	Colitis-Associated Neoplasms 01/2022 - 10/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 07/2019 - 10/2018
2	Inflammation (Inflammations) 01/2019 - 11/2013
2	Diabetes Mellitus 01/2018 - 12/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2013
2	Stroke (Strokes) 01/2016 - 09/2014
1	Primary Ovarian Insufficiency 05/2024
1	Atrophy 05/2024
1	Rheumatoid Arthritis 04/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Coronary Disease (Coronary Heart Disease) 11/2021
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Carcinogenesis 10/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Channelopathies 01/2018

Drug/Important Bio-Agent (IBA)

7	AntioxidantsIBA 05/2024 - 02/2013
4	Dextran SulfateIBA 06/2023 - 10/2020
4	3,4-dihydroxyphenyllactic acidIBA 12/2021 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2015
3	SodiumIBA 01/2024 - 02/2015
3	Interleukin-6 (Interleukin 6)IBA 12/2020 - 11/2013
3	Oxygen (Dioxygen)IBA 12/2019 - 02/2013
3	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 02/2013
3	Neuroprotective AgentsIBA 12/2019 - 02/2015
3	CytokinesIBA 01/2019 - 11/2013
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2017 - 06/2013
2	Dextrans (Dextran)FDA Link 01/2024 - 01/2023
2	arctigeninIBA 01/2024 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 04/2017
2	tetrandrineIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 11/2013
2	Sirtuin 1IBA 01/2019 - 12/2015
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2018 - 01/2018
2	Superoxide DismutaseIBA 08/2017 - 02/2013
2	Malondialdehyde (Propanedial)IBA 08/2017 - 02/2013
2	hydroxysafflor yellow AIBA 04/2017 - 09/2014
2	protocatechualdehydeIBA 01/2017 - 06/2013
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2017 - 01/2014
2	chikusetsu saponin IVaIBA 01/2016 - 12/2015
2	lithospermate BIBA 11/2013 - 02/2013
2	MB Form Creatine KinaseIBA 06/2013 - 01/2013
1	bergeninIBA 05/2024
1	triptolideIBA 05/2024
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2024
1	diallyl trisulfideIBA 06/2023
1	Cholinergic Agents (Cholinergics)IBA 04/2023
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 04/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	Butyrates (Butyrate)IBA 11/2022
1	Drinking WaterIBA 11/2022
1	madecassic acidIBA 01/2022
1	norisoboldineIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2022
1	AlkaloidsIBA 01/2022
1	TriterpenesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Amino Acids FDA Link 11/2021
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2021
1	OccludinIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Estrogen ReceptorsIBA 12/2020
1	Tamoxifen FDA LinkGeneric 12/2020
1	Neutralizing AntibodiesIBA 12/2020
1	AzoxymethaneIBA 10/2020
1	InflammasomesIBA 10/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2020
1	AmidesIBA 12/2019
1	RNA Precursors (Precursor, mRNA)IBA 07/2019
1	DystrophinIBA 07/2019
1	Protective AgentsIBA 01/2019
1	buteinIBA 01/2019

Therapy/Procedure

3	Therapeutics 12/2020 - 03/2013
3	Ligation 01/2019 - 06/2013
2	Oral Administration 11/2022 - 01/2022
1	Rectal Administration 11/2022
1	Intraperitoneal Injections 07/2022
1	Punctures 01/2019